Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Hepatocellular carcinoma: Ablate and wait versus rapid transplantation.

Roberts JP, Venook A, Kerlan R, Yao F.

Liver Transpl. 2010 Aug;16(8):925-9. doi: 10.1002/lt.22103.

2.

Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria.

Yao FY.

Am J Transplant. 2008 Oct;8(10):1982-9. doi: 10.1111/j.1600-6143.2008.02351.x. Epub 2008 Aug 22. Review.

3.

An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data.

Pelletier SJ, Fu S, Thyagarajan V, Romero-Marrero C, Batheja MJ, Punch JD, Magee JC, Lok AS, Fontana RJ, Marrero JA.

Liver Transpl. 2009 Aug;15(8):859-68. doi: 10.1002/lt.21778.

4.

Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement?

Roayaie K, Feng S.

Liver Transpl. 2007 Nov;13(11 Suppl 2):S36-43. Review.

5.

Management of hepatocellular carcinoma on the waiting list before liver transplantation: time for controlled trials?

Majno P, Giostra E, Mentha G.

Liver Transpl. 2007 Nov;13(11 Suppl 2):S27-35. Review. No abstract available.

6.

Results of liver transplantation: with or without Milan criteria?

Mazzaferro V.

Liver Transpl. 2007 Nov;13(11 Suppl 2):S44-7. Review. No abstract available.

7.

Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma.

Otto G, Herber S, Heise M, Lohse AW, Mönch C, Bittinger F, Hoppe-Lotichius M, Schuchmann M, Victor A, Pitton M.

Liver Transpl. 2006 Aug;12(8):1260-7.

8.

Liver transplantation for hepatocellular carcinoma in Asia.

de Villa V, Lo CM.

Oncologist. 2007 Nov;12(11):1321-31. Review.

9.

Extending indication: role of living donor liver transplantation for hepatocellular carcinoma.

Todo S, Furukawa H, Tada M; Japanese Liver Transplantation Study Group.

Liver Transpl. 2007 Nov;13(11 Suppl 2):S48-54.

10.

Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria.

D'Amico F, Schwartz M, Vitale A, Tabrizian P, Roayaie S, Thung S, Guido M, del Rio Martin J, Schiano T, Cillo U.

Liver Transpl. 2009 Oct;15(10):1278-87. doi: 10.1002/lt.21842.

11.

Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival.

Vakili K, Pomposelli JJ, Cheah YL, Akoad M, Lewis WD, Khettry U, Gordon F, Khwaja K, Jenkins R, Pomfret EA.

Liver Transpl. 2009 Dec;15(12):1861-6. doi: 10.1002/lt.21940.

12.

Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time.

Decaens T, Roudot-Thoraval F, Hadni-Bresson S, Meyer C, Gugenheim J, Durand F, Bernard PH, Boillot O, Sulpice L, Calmus Y, Hardwigsen J, Ducerf C, Pageaux GP, Dharancy S, Chazouilleres O, Cherqui D, Duvoux C.

Liver Transpl. 2006 Dec;12(12):1761-9.

13.

Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma.

Millonig G, Graziadei IW, Freund MC, Jaschke W, Stadlmann S, Ladurner R, Margreiter R, Vogel W.

Liver Transpl. 2007 Feb;13(2):272-9.

14.

Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome.

Graziadei IW, Sandmueller H, Waldenberger P, Koenigsrainer A, Nachbaur K, Jaschke W, Margreiter R, Vogel W.

Liver Transpl. 2003 Jun;9(6):557-63.

15.

The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma.

Dhanasekaran R, Khanna V, Kooby DA, Spivey JR, Parekh S, Knechtle SJ, Carew JD, Kauh JS, Kim HS.

J Vasc Interv Radiol. 2010 Aug;21(8):1197-204; quiz 204. doi: 10.1016/j.jvir.2010.04.018.

PMID:
20656222
16.

Current approach to down-staging of hepatocellular carcinoma prior to liver transplantation.

Hanje AJ, Yao FY.

Curr Opin Organ Transplant. 2008 Jun;13(3):234-40. doi: 10.1097/MOT.0b013e3282fc2633. Review.

PMID:
18685309
17.

Liver transplantation for hepatocellular carcinoma: University Hospital Essen experience and metaanalysis of prognostic factors.

Sotiropoulos GC, Lang H, Nadalin S, Neuhäuser M, Molmenti EP, Baba HA, Paul A, Saner FH, Weber F, Hilgard P, Frilling A, Broelsch CE, Malagó M.

J Am Coll Surg. 2007 Nov;205(5):661-75. Epub 2007 Sep 10.

PMID:
17964442
18.

Liver transplantation for hepatocellular carcinoma: results of a multicenter study with common priorization criteria.

Santoyo J, Sanchez B, de la Mata M, Fernández-Aguilar JL, Lopez-Ciller P, Pascasio JM, Suarez MA, Gomez MA, Nogueras F, Muffak K, Cuende N, Alonso M.

Transplant Proc. 2009 Apr;41(3):1009-11. doi: 10.1016/j.transproceed.2009.02.028.

PMID:
19376412
19.

Liver transplantation for hepatocellular carcinoma in patients beyond the Milan but within the UCSF criteria.

Sotiropoulos GC, Molmenti EP, Omar OS, Bockhorn M, Brokalaki EI, Lang H, Frilling A, Broelsch CE, Malagó M.

Eur J Med Res. 2006 Nov 30;11(11):467-70.

PMID:
17182358
20.

Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria.

De Giorgio M, Vezzoli S, Cohen E, Armellini E, Lucà MG, Verga G, Pinelli D, Nani R, Valsecchi MG, Antolini L, Colledan M, Fagiuoli S, Strazzabosco M.

Liver Transpl. 2010 Apr;16(4):503-12. doi: 10.1002/lt.22039.

Items per page

Supplemental Content

Write to the Help Desk